Yuan Zhi
Stock Analyst at B. Riley Securities
(1.93)
# 3,175
Out of 4,987 analysts
27
Total ratings
38.46%
Success rate
-3.68%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $22.70 | -3.08% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $2.99 | +100.67% | 1 | Jul 16, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.04 | +294.74% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $75.20 | -8.24% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.41 | -29.08% | 2 | May 15, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $7.10 | +111.27% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $7.62 | +4.99% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $4.55 | +295.60% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.87 | +69.11% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.90 | +231.79% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $30.46 | +159.36% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.61 | +893.79% | 4 | Dec 11, 2023 |
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $22.70
Upside: -3.08%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $2.99
Upside: +100.67%
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.04
Upside: +294.74%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $75.20
Upside: -8.24%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.41
Upside: -29.08%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $7.10
Upside: +111.27%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $7.62
Upside: +4.99%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $4.55
Upside: +295.60%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.87
Upside: +69.11%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.90
Upside: +231.79%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $30.46
Upside: +159.36%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.61
Upside: +893.79%